Lisa Bero, PhD

Dr. Bero is a pharmacologist with primary interest in how clinical and basic sciences are translated into clinical practice and health policy.  She has developed and validated methods for assessing the quality of research and scientific publication. Lisa A. Bero, PhD, Professor, Department of Clinical Pharmacy, School of Pharmacy and Institute for Health Policy Studies, School of Medicine, University of California, San Francisco, is a pharmacologist with primary interests in how clinical and basic sciences are translated into clinical practice and health policy.  She is Vice Chair in the Department of Clinical Pharmacy, and Chair of the UCSF Chancellor’s Advisory Committee on Conflicts of Interest.  She has developed and validated methods for assessing the quality of research and scientific publication and measures influences on the quality of research, including university-industry relations. Dr. Bero has also conducted analyses to examine the dissemination and policy implications of scientific publications. She has published numerous peer-reviewed scientific articles related to her research as well as co-authored The Cigarette Papers (UC Press, 1996). Her international activities include: advisor to the World Health Organization Drug Action Programme and Tobacco Free Initiative.  She is Co-Director of the San Francisco Branch of the United States Cochrane Center.  She is a senior editor for Tobacco Control and editor for the Cochrane Effective Practice and Organization of Care Group -- an international group of researchers conducting meta-analyses of the literature on interventions to change health professional behavior.  She has also been elected as a member of the Cochrane Collaboration Steering Group and serves on several national and international committees related to technology assessment.